Medication info
Rabeto Tablets 20mg (Rabeprazole Sodium)

Rabeto Tablets 20mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Cosmax Pharma Co., Ltd.
Appearance
Light yellow round enteric-coated tablet
Packaging
Alu Alu - 28 tablets/Alu-Alu[(14 tablets/Alu Alu packaging X 2)]
Approval status
Active

MFDS item code 201805356 · Approved 2018.12.28 · Insurance code 055100430

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination for eradication), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcers, duodenal ulcers The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled using an on-demand regimen of 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication It is recommended that this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g be administered together twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Cosmax Pharma Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination for eradication), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • Helicobacter pylori infection
  • Zollinger-Ellison syndrome
View approved original text

This medicine is used for the treatment of ulcers occurring in the stomach and duodenum. It is also effective in alleviating symptoms of gastroesophageal reflux disease and for long-term maintenance therapy. For patients with gastrointestinal ulcers infected with Helicobacter pylori, it helps in treatment when used in combination with antibiotics. It is also used to treat conditions caused by excessive gastric acid secretion, such as Zollinger-Ellison syndrome. Therefore, it is used for the treatment of various gastric and esophageal-related diseases.

How to take

Adult dose

Gastric ulcers, duodenal ulcers The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled using an on-demand regimen of 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication It is recommended that this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g be administered together twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily.

Child dose

Safety in children has not been established.

Precautions

This medication should not be administered to patients who have hypersensitivity to certain components or benzimidazole derivatives or have a history of such reactions. Additionally, patients allergic to penicillin-based antibiotics or macrolide antibiotics should refrain from using this medication. In particular, when used for the eradication of Helicobacter pylori, it is essential to verify any allergies to the antibiotics used in combination. This medication is prohibited for use in pregnant or breastfeeding women and should not be used by patients taking certain medications such as atazanavir or rilpivirine. It must be administered cautiously to patients with liver function issues, the elderly, and those with a history of drug allergies, and any adverse reactions should be immediately discussed with healthcare professionals. Various side effects such as skin rashes, itching, blood abnormalities, liver function abnormalities, cardiovascular issues, gastrointestinal disturbances, and neurological symptoms may occur while taking this medication, necessitating regular check-ups and monitoring. It is particularly important to undergo periodic liver function and blood tests, and if abnormal symptoms arise, medication should be promptly discontinued and appropriate measures taken. Long-term use may increase the risk of osteoporosis and fractures, so patients on long-term therapy should pay attention to bone density management. Additionally, as this medication strongly suppresses gastric acid secretion, there may be a slight increase in the risk of gastrointestinal bacterial infections; thus, any abnormal symptoms like diarrhea should be reported to healthcare professionals. Caution should also be taken as drowsiness may occur when driving or operating machinery. There is potential for interactions with other medications; therefore, anyone currently taking other medications should inform their healthcare provider. In particular, caution is needed when used in conjunction with warfarin, methotrexate, antibiotics, and antiviral agents. When taking, the tablets should not be chewed or crushed but swallowed whole, and they should be stored out of the reach of children. During pregnancy or breastfeeding, this medication should not be used, and adjustments in dosing may be necessary for the elderly or patients with impaired liver function if adverse reactions occur. In case of overdose, no specific antidote exists; therefore, treatment and supportive therapy based on symptoms are necessary. Long-term use of this medication may lead to vitamin B12 deficiency, so nutritional status should be checked as needed. Furthermore, symptoms of erythematous lupus may appear after taking this medication, and if such symptoms occur, immediate consultation with healthcare professionals is required.

Side effects

  • Rash
  • urticaria
  • itching
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • neutrophilia
  • lymphocytopenia
  • hemolytic anemia
Show 163 more
  • petechia
  • lymphadenopathy
  • hypochromic anemia
  • pancytopenia
  • agranulocytosis
  • thrombocytopenia
  • hemolytic anemia
  • elevated ALT
  • elevated AST
  • elevated ALP
  • elevated γ-GTP
  • elevated LDH
  • elevated total bilirubin
  • fulminant hepatitis
  • liver dysfunction
  • jaundice
  • hypertension
  • myocardial infarction
  • abnormal electrocardiogram
  • migraine
  • syncope
  • angina
  • atrioventricular block
  • palpitations
  • bradycardia
  • tachycardia
  • pulmonary embolism
  • supraventricular tachycardia
  • thrombophlebitis
  • vasodilation
  • QTc prolongation
  • ventricular tachycardia
  • diarrhea
  • constipation
  • abdominal pain
  • abdominal distention
  • dyspepsia
  • belching
  • nausea
  • rectal bleeding
  • melena
  • anorexia
  • cholelithiasis
  • oral ulcer
  • dysphagia
  • gingivitis
  • cholecystitis
  • increased appetite
  • abnormal stools
  • colitis
  • esophagitis
  • glossitis
  • pancreatitis
  • proctitis
  • thirst
  • vomiting
  • lower abdominal pain
  • gastric body
  • gastritis
  • stomatitis
  • dysgeusia
  • hemorrhagic diarrhea
  • cholangitis
  • duodenitis
  • gastrointestinal bleeding
  • hepatic encephalopathy
  • hepatitis
  • liver cancer
  • hepatic steatosis
  • sialadenitis
  • thirst
  • headache
  • insomnia
  • anxiety
  • dizziness
  • convulsions
  • abnormal dreams
  • decreased libido
  • neuropathy
  • sensory disturbances
  • tremors
  • weakness
  • neuralgia
  • drowsiness
  • vertigo
  • depression
  • restlessness
  • amnesia
  • confusion
  • extrapyramidal syndrome
  • hypervolemia
  • limb hypotonia
  • sensory ataxia
  • decreased grip strength
  • language confusion
  • staggering
  • delirium
  • disorientation
  • hypersomnia
  • cough
  • pharyngitis
  • rhinitis
  • dyspnea
  • asthma
  • epistaxis
  • laryngitis
  • hiccups
  • hyperventilation
  • bronchitis
  • sinusitis
  • apnea
  • respiratory depression
  • interstitial pneumonia
  • myalgia
  • low back pain
  • arthritis
  • leg cramps
  • bone pain
  • arthrosis
  • bursitis
  • generalized muscle hypertonia
  • neuralgia
  • single contraction
  • sweating
  • alopecia
  • skin dryness
  • shingles
  • psoriasis
  • skin discoloration
  • toxic epidermal necrolysis
  • mucosal pemphigoid syndrome
  • erythema multiforme
  • cataract
  • amblyopia
  • glaucoma
  • dry eyes
  • abnormal vision
  • tinnitus
  • otitis media
  • corneal opacity
  • blurred vision
  • double vision
  • hearing loss
  • eye pain
  • retinal degeneration
  • strabismus
  • proteinuria
  • cystitis
  • frequent urination
  • dysmenorrhea
  • dysuria
  • nephrolithiasis
  • uterine bleeding
  • polyuria
  • gynecomastia
  • elevation of thyroid-stimulating hormone
  • visual disturbances
  • skin erythematosus lupus
  • systemic lupus erythematosus
  • skin erythema
  • arthralgia
  • leukopenia
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is between 1 to 30 degrees Celsius, maintaining room temperature.

Appearance and packaging

Appearance

Light yellow round enteric-coated tablet

Package unit

Alu Alu - 28 tablets/Alu-Alu[(14 tablets/Alu Alu packaging X 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.